{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:28:06Z","timestamp":1793042886882,"version":"4.5.0"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Toceranib phosphate (toceranib) is approved for canine mast cell tumor treatment. However, no long-term response to toceranib in canine HSTCL has been reported. Here, we describe a case of a 10-year-old castrated mixed-breed dog that presented with a 3-month history of weight loss, polydipsia, and polyuria. The clinicopathological and imaging abnormalities included icterus, biliary obstruction, and splenomegaly with multiple diffuse splenic hypoechoic nodules. On day 21, a cholecystectomy was performed to remove the obstruction, followed by a liver biopsy and splenectomy. Cytology of the spleen and liver showed many small lymphocytes with intracytoplasmic granules (sGLs). Splenic and hepatic infiltration of neoplastic CD3\/granzyme B-positive small cells and lymphocytic cholecystitis with granzyme B-negative small cells were noted. T-cell receptor gene clonal rearrangements were observed in the liver tissues. The dog was diagnosed with a hepatosplenic T-cell lymphoma (HSTCL) of sGLs concurrent with lymphocytic cholecystitis. The icterus resolved after surgery, but there was progressive elevation of liver enzyme levels. Toceranib was administered from day 39, resulting in decreased liver enzyme levels, and the dog remained in good condition. The dog stayed in remission after toceranib administration and survived for 460 days. Toceranib should be considered an effective treatment option for canine HSTCL.<\/jats:p>","DOI":"10.3390\/vetsci11100458","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T03:57:52Z","timestamp":1727755072000},"page":"458","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Survival in Canine Hepatosplenic T-Cell Lymphoma Treated with Toceranib Phosphate Following Splenectomy: A Case of Atypical Lymphoma"],"prefix":"10.3390","volume":"11","author":[{"given":"Makoto","family":"Akiyoshi","sequence":"first","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Azabu University, Sagamihara 252-5201, Kanagawa, Japan"},{"name":"Akiyoshi Animal Clinic, Yamato 242-0008, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Hisasue","sequence":"additional","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Azabu University, Sagamihara 252-5201, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori Goto","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Clinical and Anatomic Pathology Unit, Veterinary Specialists Emergency Center, Kawaguchi 333-0823, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakurako","family":"Neo","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Diagnosis, Azabu University, Sagamihara 252-5201, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1354\/vp.40-5-556","article-title":"Hepatosplenic lymphoma in a dog","volume":"40","author":"Fry","year":"2003","journal-title":"Vet. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0300985812451625","article-title":"Hepatosplenic and hepatocytotropic T-cell lymphoma: Two distinct types of T-cell lymphoma in dogs","volume":"50","author":"Keller","year":"2013","journal-title":"Vet. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/vcp.12704","article-title":"A case of hemophagocytic syndrome progressing into large granular lymphoma in a dog","volume":"48","author":"Akiyoshi","year":"2019","journal-title":"Vet. Clin. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/vcp.13086","article-title":"Hepatosplenic lymphoma and visceral mast cell tumor in the liver of a dog with synchronous and multiple primary tumors","volume":"51","author":"Akiyoshi","year":"2022","journal-title":"Vet. Clin. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-08-1860","article-title":"Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision","volume":"15","author":"London","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bernabe, L.F., Portela, R., Nguyen, S., Kisseberth, W.C., Pennell, M., Yancey, M.F., and London, C.A. (2013). Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose. BMC Vet. Res., 9.","DOI":"10.1186\/1746-6148-9-190"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1476-5829.2011.00275.x","article-title":"Preliminary evidence for biologic activity of toceranib phosphate (Palladia\u00ae) in solid tumours","volume":"10","author":"London","year":"2012","journal-title":"Vet. Comp. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/vco.12091","article-title":"Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia\u00ae) in tumour-bearing dogs: A phase I dose-finding study","volume":"14","author":"Pan","year":"2016","journal-title":"Vet. Comp. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/vsu.13956","article-title":"The effect of flushing of the common bile duct on hepatobiliary markers and short-term outcomes in dogs undergoing cholecystectomy for the management of gall bladder mucocele: A randomized controlled prospective study","volume":"52","author":"Hernon","year":"2023","journal-title":"Vet. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1292\/jvms.70.127","article-title":"C-reactive protein concentration in dogs with various diseases","volume":"70","author":"Nakamura","year":"2008","journal-title":"J. Vet. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0300985813478210","article-title":"Canine lymphomas: Association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival","volume":"50","author":"Valli","year":"2013","journal-title":"Vet. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1111\/cas.14118","article-title":"Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture","volume":"110","author":"Elbadawy","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Elbadawy, M., Fujisaka, K., Yamamoto, H., Tsunedomi, R., Nagano, H., Ayame, H., Ishihara, Y., Mori, T., Azakami, D., and Uchide, T. (2022). Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method. Biomed. Pharmacother., 151.","DOI":"10.1016\/j.biopha.2022.113105"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sato, Y., Elbadawy, M., Suzuki, K., Tsunedomi, R., Nagano, H., Ishihara, Y., Yamamoto, H., Azakami, D., Uchide, T., and Nabeta, R. (2023). Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method. Biomed. Pharmacother., 162.","DOI":"10.1016\/j.biopha.2023.114651"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Veterinary Co-Operative Oncology Group (2016). Veterinary cooperative oncology group\u2014Common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1. Vet. Comp. Oncol., 14, 417\u2013446.","DOI":"10.1111\/vco.283"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/vco.12959","article-title":"Large granular lymphocyte lymphoma in 65 dogs (2005\u20132023)","volume":"22","author":"Yale","year":"2024","journal-title":"Vet. Comp. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1939-165X.2004.tb00357.x","article-title":"Morphologic, immunohistochemical, and molecular characterization of hepatosplenic T-cell lymphoma in a dog","volume":"33","author":"Cienava","year":"2004","journal-title":"Vet. Clin. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.vetimm.2017.07.008","article-title":"Specific immunotypes of canine T cell lymphoma are associated with different outcomes","volume":"191","author":"Deravi","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1292\/jvms.17-0619","article-title":"Lymphoma-associated hemophagocytic syndrome in six dogs","volume":"80","author":"Suwa","year":"2018","journal-title":"J. Vet. Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/0300985821999831","article-title":"Review of Histological Grading Systems in Veterinary Medicine","volume":"58","author":"Avallone","year":"2021","journal-title":"Vet. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/vcp.12809","article-title":"Chronic lymphopenia and neutropenia in a dog with large granular lymphocytic leukemia","volume":"48","author":"Museux","year":"2019","journal-title":"Vet. Clin. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/vco.12384","article-title":"Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma","volume":"16","author":"Couto","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jsap.12769","article-title":"Low-grade gastrointestinal lymphoma in dogs: 20 cases (2010 to 2016)","volume":"59","author":"Lane","year":"2018","journal-title":"J. Small Anim. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jvim.14866","article-title":"Cholangitis and Cholangiohepatitis in Dogs: A Descriptive Study of 54 Cases Based on Histopathologic Diagnosis (2004\u20132014)","volume":"32","author":"Harrison","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jvim.16922","article-title":"Concurrent hepatopathy in dogs with gallbladder mucocele: Prevalence, predictors, and impact on long-term outcome","volume":"38","author":"Jablonski","year":"2024","journal-title":"J. Vet. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2460\/javma.239.7.966","article-title":"Clinical characteristics, treatment, and outcome of dogs with presumed primary hepatic lymphoma: 18 cases (1992\u20132008)","volume":"239","author":"Dank","year":"2011","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1292\/jvms.16-0457","article-title":"Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs","volume":"79","author":"Yamazaki","year":"2017","journal-title":"J. Vet. Med. Sci."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/11\/10\/458\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:08:17Z","timestamp":1760112497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/11\/10\/458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["vetsci11100458"],"URL":"https:\/\/doi.org\/10.3390\/vetsci11100458","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}